---
document_datetime: 2023-09-21 18:31:19
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/trelegy-ellipta-epar-all-authorised-presentations_en.pdf
document_name: trelegy-ellipta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8216846
conversion_datetime: 2025-12-28 05:41:13.011857
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength              | Pharmaceutical form              | Route of administration   | Immediate Packaging   | Pack size                             |
|------------------|-------------------|-----------------------|----------------------------------|---------------------------|-----------------------|---------------------------------------|
| EU/1/17/1236/001 | Trelegy Ellipta   | 92 µg / 55 µg / 22 µg | Inhalation powder, pre-dispensed | Inhalation use            | Blister (alu)         | 1 inhaler (14 doses)                  |
| EU/1/17/1236/002 | Trelegy Ellipta   | 92 µg / 55 µg / 22 µg | Inhalation powder, pre-dispensed | Inhalation use            | Blister (alu)         | 1 inhaler (30 doses)                  |
| EU/1/17/1236/003 | Trelegy Ellipta   | 92 µg / 55 µg / 22 µg | Inhalation powder, pre-dispensed | Inhalation use            | Blister (alu)         | 3 inhalers (3 x 30 doses) (multipack) |